Breckenridge Pharmaceutical has issued a significant voluntary recall affecting over 375,000 bottles of Duloxetine Delayed-Release Capsules, an SNRI medication commonly prescribed for depression, anxiety, and neuropathic pain. The recall, initiated in June 2026, marks the latest in a series of market withdrawals by the company over the past two years relating to the same safety concern.
The Cause: Nitrosamine Impurities
The core issue driving the recall is the detection of N-nitroso-duloxetine, a nitrosamine impurity found in the affected batches at levels that exceed the strict daily intake limits recommended by the U.S. Food and Drug Administration (FDA).
Nitrosamines are common compounds found in water and everyday foods, including cured and grilled meats. However, prolonged exposure to these impurities at higher-than-acceptable levels over long periods can increase the risk of cancer, leading regulatory agencies to strictly monitor their presence in pharmaceutical products.
Details of the Current Recall
The June 2026 recall specifically targets multiple lots of the medication, encompassing both the 30mg and 60mg dosages:
- 30mg Capsules: Identified under NDC 51991-747-10.
- 60mg Capsules: Identified under NDC 51991-748-90 and NDC 51991-748-10.
The expiration dates on the affected bottles range from November 2026 through May 2027.
This is not an isolated incident for Breckenridge Pharmaceutical. The company navigated a series of similar, large-scale recalls throughout 2024 and 2025 as the pharmaceutical industry at large continues to grapple with the complex challenge of nitrosamine contamination in drug manufacturing processes.
Critical Patient Guidance
For patients currently taking duloxetine, the FDA and healthcare professionals emphasize one critical directive: Do not stop taking your medication abruptly.
Duloxetine is known to cause severe withdrawal symptoms—often referred to as discontinuation syndrome—if stopped suddenly. Symptoms can include dizziness, nausea, headache, paresthesia (brain zaps), and intense mood fluctuations.
If you are taking Breckenridge-manufactured duloxetine, you should take the following steps:
- Check your bottle: Look for the manufacturer name (Breckenridge Pharmaceutical) and the lot number on your prescription label.
- Contact your pharmacist: If the lot number matches the recalled batches, your pharmacist can verify the recall and provide a safe replacement from an unaffected batch or a different manufacturer.
- Consult your doctor: Discuss any concerns about your treatment plan or potential alternatives with your prescribing physician.
Maintaining patient safety while avoiding the risks of sudden drug discontinuation remains the highest priority for healthcare providers managing this ongoing recall.
